A. Garlind et al., INTRACELLULAR INOSITOL(1,4,5)-TRISPHOSPHATE RECEPTOR LEVELS ARE PRESERVED IN ALZHEIMERS-DISEASE PLATELETS, Neurobiology of aging, 18(5), 1997, pp. 559-561
An increasing number of signal transduction disturbances have been rep
orted in Alzheimer's disease. These changes are not restricted to hist
opathologically changed brain areas but are seen also in peripheral ti
ssues. One of the most severe disturbances is a loss of calcium-mobili
zing intracellular inositol(1,4,5)trisphosphate receptors in Alzheimer
cerebellar and cortical tissues. In the present study, the binding of
[H-3]inositol(1,4,5)trisphosphate ([H-3]Ins(1,4,5)P-3) to the calcium
-mobilizing inositol(1,4,5)trisphosphate receptors in platelet membran
es from eight Alzheimer's disease patients and eight control subjects
were investigated to determine its possible role as a biological marke
r in Alzheimer's disease. It was found that there were no significant
difference in [H-3]Ins(1,4,5)P-3 binding with respect to the number of
sites measured at different protein concentrations or to the sensitiv
ity of the binding to inhibition by nonradioactive Ins(1,4,5)P-3 betwe
en Alzheimer disease platelets and controls. It is concluded that inos
itol(1,4,5)trisphosphate receptor levels are preserved in platelets fr
om patients with Alzheimer's disease. (C) 1997 Elsevier Science Inc.